(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT

ST13

US500000087982217

Class

42

Filing

87982217

Registration

5962396

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

04/03/2026

Trademark type

Combined

Nice classes

42

Filing date

05/09/2018

Registration date

01/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/02/2026

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/03/2019

First use in commerce

01/03/2019

Drawing code

3

Owner type

16

Owner location

San Mateo, CA, KY

Examiner

ORTIGA PALMER, RAMONA

Current location

Historical data usage

Mark description

The mark consists of a capitalized letter "B", followed by a lower case "r", followed by geometric shapes organized to represent two lower case letter "i's" as well as human figures, followed by the word "Biosciences". The words "Breakthrough Innovation & Insight" are centered directly below the words "Brii Biosciences".

Holders and representatives

Holders

BRII BIOSCIENCES LIMITED
BRII BIOSCIENCES LIMITED
BiiG THERAPEUTICS LIMITED

Representatives

Scott W. Pink O'Melveny & Myers

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases; research and development in the pharmaceuticallife sciences and biotechnology fields

Publications

History of USPTO decisions and trademark events.

38 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/02/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/02/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/01/2026

E815

TEAS SECTION 8 & 15 RECEIVED

01/06/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/10/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/09/2019

DPCC

DIVISIONAL PROCESSING COMPLETE

10/31/2019

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/31/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/30/2019

EX1G

SOU EXTENSION 1 GRANTED

10/30/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/29/2019

DRRR

DIVISIONAL REQUEST RECEIVED

10/16/2019

IUAF

USE AMENDMENT FILED

10/16/2019

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

10/16/2019

EXT1

SOU EXTENSION 1 FILED

10/16/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/16/2019

EISU

TEAS STATEMENT OF USE RECEIVED

10/16/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/16/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/19/2019

PUBO

PUBLISHED FOR OPPOSITION

02/19/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/30/2019

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/09/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/20/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/14/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/13/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/13/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/31/2018

UNDC

UNDELIVERABLE MAIL - COURTESY COPY MAILED

09/20/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/12/2018

GNRT

NON-FINAL ACTION E-MAILED

09/12/2018

CNRT

NON-FINAL ACTION WRITTEN

09/12/2018

DOCK

ASSIGNED TO EXAMINER

08/30/2018

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/18/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2018

NWAP

NEW APPLICATION ENTERED

05/12/2018

Continuous trademark protection

Get notified about every new filing that threatens BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.